Frequently Asked Questions
-
Your provider will review your health history, weight-loss goals, current medications, previous treatments, and lab results when appropriate. From there, we can discuss options such as semaglutide, tirzepatide, or other medically appropriate treatments and recommend a plan that fits your needs.
-
No. UmmiHealth offers options based on your preferences and eligibility. Depending on your treatment plan, this may include FDA-approved brand-name medication, prescription support for medications filled through a pharmacy or manufacturer program, or compounded medication when clinically appropriate.
-
Our monthly GLP-1 plans start at about $85/week ($340/month for semaglutide, $540/month for tirzepatide), and include your weekly injections, ongoing monitoring, side-effect support and dose adjustments. A new-patient visit is $180, a brand-name GLP-1 consultation is $95, and GLP-1 coaching is $45 per session. We believe in transparent pricing and will explain your expected costs before you begin treatment.
-
Coverage varies widely by insurance plan and medication. Some plans cover medications such as Wegovy or Zepbound, while others exclude weight-loss treatment. We can discuss prescription options and available pathways, but insurance coverage is ultimately determined by your plan.
-
Your first visit includes a review of your medical history, weight history, current medications, lifestyle, goals, and previous weight-loss attempts. Your provider will discuss treatment options, answer your questions, and create a personalized plan.
-
Yes. If you are already using semaglutide, tirzepatide, or another weight-management medication, we can review your current treatment and determine the safest and most appropriate next step. Please bring your current medication information and dose to your appointment.
-
Lab testing may be recommended based on your medical history, symptoms, and treatment plan. When appropriate, bloodwork can also help us better understand your metabolic health and identify factors that may affect your weight or overall health.
-
Most patients notice less appetite within the first one to two weeks, and visible weight loss usually follows in the first 4–8 weeks. Because we raise your dose gradually to keep side effects low, results build over time: in major clinical trials, people lost an average of about 15% of their body weight on semaglutide and about 21% on tirzepatide over roughly 16–17 months. Your own pace depends on your dose, starting weight, nutrition, sleep, activity and hormones. We track your progress at every visit and adjust your plan so you keep moving forward.
-
Common side effects can include nausea, constipation, diarrhea, decreased appetite, or stomach discomfort. Your provider can help you manage symptoms, adjust your treatment when appropriate, and determine whether a different dose or medication may be a better fit.
-
Yes. Weight management is an ongoing process. Follow-up visits allow us to monitor your progress, review side effects, adjust your dose or treatment plan, and help you navigate nutrition, lifestyle changes, and plateaus along the way.
-
Obesity is a chronic condition, and research shows many people regain weight after stopping GLP-1 medications abruptly. That’s why we build a long-term plan with you, including nutrition, strength-training guidance, and options to taper or stay on a maintenance dose, so your results last.